183 related articles for article (PubMed ID: 21468013)
1. The incidence and clinical spectrum of refractory celiac disease in a north american referral center.
Roshan B; Leffler DA; Jamma S; Dennis M; Sheth S; Falchuk K; Najarian R; Goldsmith J; Tariq S; Schuppan D; Kelly CP
Am J Gastroenterol; 2011 May; 106(5):923-8. PubMed ID: 21468013
[TBL] [Abstract][Full Text] [Related]
2. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
3. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands.
van Wanrooij RL; Bouma G; Bontkes HJ; Neefjes-Borst A; van Grieken NC; von Blomberg BM; Mulder CJ
Clin Transl Gastroenterol; 2017 Jan; 8(1):e218. PubMed ID: 28125074
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional imaging in refractory celiac disease.
Al-Bawardy B; Barlow JM; Vasconcelos RN; Kim ST; Bruining DH; Hansel SL; Sheedy SP; Murray JA; Rubio-Tapia A; Rajan E; Fidler JL; Fletcher JG
Abdom Radiol (NY); 2017 Feb; 42(2):389-395. PubMed ID: 28084545
[TBL] [Abstract][Full Text] [Related]
6. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
[TBL] [Abstract][Full Text] [Related]
8. T-cell repertoires in refractory coeliac disease.
Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
[TBL] [Abstract][Full Text] [Related]
9. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
10. Clinical Insignficance of Monoclonal T-Cell Populations and Duodenal Intraepithelial T-Cell Phenotypes in Celiac and Nonceliac Patients.
Celli R; Hui P; Triscott H; Bogardus S; Gibson J; Hwang M; Robert ME
Am J Surg Pathol; 2019 Feb; 43(2):151-160. PubMed ID: 30334829
[TBL] [Abstract][Full Text] [Related]
11. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease.
Olaussen RW; Løvik A; Tollefsen S; Andresen PA; Vatn MH; De Lange T; Bratlie J; Brandtzaeg P; Farstad IN; Lundin KE
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):875-85. PubMed ID: 16234025
[TBL] [Abstract][Full Text] [Related]
12. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system.
Soderquist CR; Hsiao S; Mansukhani MM; Alobeid B; Green PH; Bhagat G
Hematol Oncol; 2020 Aug; 38(3):399-405. PubMed ID: 32010998
[TBL] [Abstract][Full Text] [Related]
13. Classification and management of refractory coeliac disease.
Rubio-Tapia A; Murray JA
Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
15. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease.
Di Sabatino A; Giuffrida P; Vanoli A; Luinetti O; Manca R; Biancheri P; Bergamaschi G; Alvisi C; Pasini A; Salvatore C; Biagi F; Solcia E; Corazza GR
Am J Gastroenterol; 2014 Feb; 109(2):258-69. PubMed ID: 24394748
[TBL] [Abstract][Full Text] [Related]
16. MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system.
Van Weyenberg SJ; Meijerink MR; Jacobs MA; van Kuijk C; Mulder CJ; van Waesberghe JH
Radiology; 2011 Apr; 259(1):151-61. PubMed ID: 21330559
[TBL] [Abstract][Full Text] [Related]
17. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
[TBL] [Abstract][Full Text] [Related]
18. Refractory celiac disease: from bench to bedside.
Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
[TBL] [Abstract][Full Text] [Related]
19. TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease.
Perfetti V; Brunetti L; Biagi F; Ciccocioppo R; Bianchi PI; Corazza GR
J Clin Gastroenterol; 2012 Sep; 46(8):675-9. PubMed ID: 22298086
[TBL] [Abstract][Full Text] [Related]
20. Refractory celiac disease.
Abdallah H; Leffler D; Dennis M; Kelly CP
Curr Gastroenterol Rep; 2007 Oct; 9(5):401-5. PubMed ID: 17991341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
